share_log

Cathie Wood Trims Pfizer Stake And Loads Up $25M In Rival COVID-19 Vaccine Maker

Cathie Wood Trims Pfizer Stake And Loads Up $25M In Rival COVID-19 Vaccine Maker

凯西·伍德减持辉瑞股份,斥资2500万美元入股竞争对手新冠肺炎疫苗制造商
Benzinga Real-time News ·  2022/06/09 00:04

Cathie Wood led Ark Invest on Wednesday initiated a position in $Moderna(MRNA.US)$ after the biotech company said an updated version of its COVID-19 booster vaccine appeared to provide stronger protection against the Omicron variant than its current shot. 

凯西·伍德领头方舟 投资周三提出了一个职位,$Moderna(MRNA.US)$此前,这家生物技术公司表示,其更新版本的新冠肺炎加强疫苗似乎比目前的疫苗对奥密克戎变异病毒提供了更强的保护。

St. Petersburg, Florida-based Ark Invest bought 172,939 shares, estimated to be worth $25.68 million, in Moderna.

总部位于佛罗里达州圣彼得堡的Ark Invest在Moderna购买了172,939股票,估计价值2,568万美元。

Moderna closed 2.2% higher at $148.5 on Wednesday. The stock, which is down 36.8% so far this year, has risen 9% in the past month.

Moderna周三收高2.2%,报148.5美元。该股今年迄今下跌36.8%,过去一个月上涨9%。

Ark Invest bought the Moderna shares via its flagship pharma-linked exchange fund Ark Genomic Revolution ETF (BATS: ARKG) on Wednesday. 

方舟投资通过其旗舰制药关联交易所基金购买了Moderna的股票方舟基因革命ETF(蝙蝠:ARKG)周三。

See Also: Moderna's Updated COVID-19 Shot Boosts Omicron Protection

另见:Moderna更新新冠肺炎推送奥密克戎保护

The money managing firm, however, sold 152,823 shares — estimated to be worth $8.17 million — in rival Pfizer Inc (NYSE: PFE) on Wednesday. 

然而,这家资金管理公司在竞争对手手中出售了152,823股--估计价值817万美元辉瑞(纽约证券交易所代码:PFE)周三。

Shares of the biotech firm, which is boosting production of its oral COVID-19 pill, closed 0.9% lower at $53.4. The stock is down 5.6% year-to-date. Pfizer has been seeking FDA approval for three COVID-19 vaccine doses for children under five.

这家生物科技公司正在提高其口头新冠肺炎口服药的产量,其股价收盘下跌0.9%,至53.4美元。今年到目前为止,该股下跌了5.6%。辉瑞公司一直在寻求FDA批准为五岁以下儿童接种三剂新冠肺炎疫苗。

Ark Invest held 732, 993 shares, worth $39.5 million, in Pfizer before Wednesday's trade. The investment firm has been selling shares in Pfizer for months now.

周三交易前,Ark Invest持有辉瑞732,993股,价值3,950万美元。这家投资公司几个月来一直在出售辉瑞的股票。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发